News | April 28, 2026
Jagsonpal Pharma profit surges 31% in Q4
Rs. 40 cr buyback, 200% dividend announced
Rs. 40 cr buyback, 200% dividend announced
New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
The product is manufactured at AKUMS’ state-of-the-art injectable facility in Kotdwar, Uttarakhand
The capital will be deployed to deepen AI-driven personalisation capabilities, expand its dark store network, and build a strong offline retail presence
The company achieved 20% EBITDA profitability in Bengaluru and reached operational profitability across all its active cities
Experts call for integrated, evidence-based approaches to tackle rising dengue, malaria, and chikungunya burden in Indian cities
The lens received U.S. Food and Drug Administration (FDA) market authorization via the De Novo pathway in late 2025
The centre will leverage AI-enabled tools to support research and diagnostics for complex eye–brain disorders
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
India leads the shift as wellness tourism integrates healthcare, hospitality, and lifestyle
Subscribe To Our Newsletter & Stay Updated
